title: Artesunate for severe acute Plasmodium falciparum infection in a patient with myasthenia gravis.
abstract: We report a case of severe malaria in a patient with underlying myasthenia gravis who was successfully treated with artesunate. The outcome was favorable. Artesunate seems to be a good option for patients with underlying myasthenia gravis disease because they benefit from a better toxicity profile than quinine.
authors: Infectious and Tropical Diseases Unit, Parasitology and Mycology Unit, and French National Center for Metropolitan Malaria, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. na_dournon@hotmail.com
authors: Nathalie
authors: N
authors: Dournon
authors: Pierre
authors: P
authors: Buffet
authors: Eric
authors: E
authors: Caumes
authors: Bernard
authors: B
authors: Clair
authors: Stéphane
authors: S
authors: Jauréguiberry
mesh_terms: D000328:Adult; D037621:Artemisinins / Q000627:therapeutic use*; D000077332:Artesunate; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D009157:Myasthenia Gravis / Q000469:parasitology*; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000472:pathogenicity; D016896:Treatment Outcome
chemical_list: D037621:Artemisinins; D000077332:Artesunate